Ratings Summary for LAMISIL AT

Overall Patient opinion of LAMISIL AT: 2.3 (not satisfied)

(based on 588 reviews ) (updated May 6, 2025)

Ratings by Age Group for LAMISIL AT
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)
Age 18 to 24	25	3
Age 25 to 34	114	3
Age 35 to 44	164	2.4
Age 45 to 54	163	2.0
Age 55 to 64	83	1.6
Age 65 to 74	22	2
Age 75 and up	3	1

Ratings by Sex for LAMISIL AT
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	201	2.49253731343284
Female	379	2.22691292875989
Not Specified	8	2.5

Would you like to find reviews for LAMISIL AT taken for a specific reason or resulting in a specific side effect?

Filter Results for LAMISIL AT

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for LAMISIL AT

Check here for Ask a Patient's Adverse Event Summary for LAMISIL AT based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

LAMISIL AT (): FDA Approval Date: (Sources: U.S. Centers for Medicare Services, FDA)

Patient Counseling Information from Official Drug Label

The above Patient Counseling and/or Medication Guide for LAMISIL AT is from the official drug label (including Section 17) obtained from the National Library of Medicine's DailyMed database.
Please refer to the complete label here Official Drug Label for LAMISIL AT.